BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2017 2:36:58 AM | Browse: 1069 | Download: 1254
Publication Name World Journal of Gastroenterology
Manuscript ID 35031
Country/Territory Pakistan
Received
2017-07-11 20:58
Peer-Review Started
2017-07-12 01:39
To Make the First Decision
2017-08-10 00:15
Return for Revision
2017-08-10 06:51
Revised
2017-09-06 09:14
Second Decision
2017-09-08 02:07
Accepted by Journal Editor-in-Chief
2017-09-08 21:32
Accepted by Company Editor-in-Chief
2017-09-13 03:02
Articles in Press
2017-09-13 03:02
Publication Fee Transferred
2017-09-22 05:26
Edit the Manuscript by Language Editor
2017-11-08 23:39
Typeset the Manuscript
2017-11-17 02:33
Publish the Manuscript Online
2017-11-27 02:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Dramatic response of hepatitis C patients chronically infected with Hepatitis C virus genotype 3 to Sofosbuvir based therapies in Punjab, Pakistan: A prospective study
Manuscript Source Unsolicited Manuscript
All Author List Sajjad Iqbal, Muhammad Haroon Yousuf and Muhammad Iftikhar Yousaf
ORCID
Author(s) ORCID Number
Sajjad Iqbal http://orcid.org/orcid.org/0000-0001-7476-7552
Muhammad Haroon Yousuf http://orcid.org/orcid.org/0000-0001-5448-0781
Muhammad Iftikhar Yousaf http://orcid.org/orcid.org/0000-0002-5099-9022
Funding Agency and Grant Number
Corresponding Author Sajjad Iqbal, PhD, Doctor, Pathology, Shalamar Hospital, Shalimar Link road Mughal Pura, Lahore 54840, Punjab, Pakistan. sajjad.iqbal@sihs.org.pk
Key Words Sofosbuvir; Sustained virological response; Pakistan
Core Tip Previously, Hepatitis C was treated with Interferon based therapies. Intolerable side effects, prolonged treatment duration, and unsatisfactory response rates were the major droughts of those therapies. The introduction of Sofosbuvir (SOF) that was claimed highly responding oral drug for Hapatitis C patients with its minimal side effects in different trials, it was important to see its efficacy in our population. We found outstanding response rate of SOF in HCV genotype 3 infected patients. These findings shows that with proper and timely use of SOF based therapy may help to get rid of Hepatitis C from our population.
Publish Date 2017-11-27 02:36
Citation Iqbal S, Yousuf MH, Yousaf MI. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study. World J Gastroenterol 2017; 23(44): 7899-7905
URL http://www.wjgnet.com/1007-9327/full/v23/ i44/7899.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i44.7899
Full Article (PDF) WJG-23-7899.pdf
Full Article (Word) WJG-23-7899.doc
Manuscript File 35031-Review.docx
Answering Reviewers 35031-Answering reviewers.pdf
Audio Core Tip 35031-Audio core tip.m4a
Biostatistics Review Certificate 35031-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 35031-Conflict-of-interest statement.pdf
Copyright License Agreement 35031-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s) 35031-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 35031-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 35031-Language certificate.pdf
Supplementary Material 35031-Supplementary-Material-revision.pdf
Peer-review Report 35031-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 35031-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 35031-Scientific misconduct check.pdf
Scientific Editor Work List 35031-Scientific editor work list.pdf